SCHEMBL7120550

SCHEMBL7120550

COc1ccc2c(-c3ccccc3)c(-c3ccc(Cl)cc3)c(=O)oc2c1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 3/20 0.72
CA1 P00915 4/20 0.61
CA2 P00918 4/20 0.61
ALDH1A1 P00352 6/20 0.58
CYP1A2 P05177 1/20 0.58
CYP2C9 P11712 1/20 0.58
CYP2C19 P33261 1/20 0.58
KDM4E B2RXH2 5/20 0.56
MAPT P10636 3/20 0.56
LMNA P02545 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
TNKS O95271 1/20 0.55
HPGD P15428 2/20 0.53
HSD17B10 Q99714 2/20 0.53
GAA P10253 1/20 0.53
KMT2A Q03164 2/20 0.52
MEN1 O00255 1/20 0.52
CYP3A4 P08684 1/20 0.52
THRB P10828 1/20 0.52
NPC1 O15118 5/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7117813 0.92 ALDH1A1 (0.64) CYP19A1CA1CA2ALDH1A1CYP1A2
SCHEMBL7117556 0.92 ALDH1A1 (0.67) CYP19A1CA1CA2ALDH1A1CYP1A2
SCHEMBL5145814 0.89 ESR1 (0.63) CYP19A1CA1CA2ALDH1A1CYP2C9
SCHEMBL13819275 0.89 ALDH1A1 (0.63) CYP19A1CA1CA2ALDH1A1CYP1A2
SCHEMBL7155199 0.88 ALDH1A1 (0.58) CYP19A1CA1CA2ALDH1A1CYP1A2
SCHEMBL8934549 0.88 CA1 (0.64) CYP19A1CA1CA2ALDH1A1CYP1A2
SCHEMBL14389075 0.88 ALDH1A1 (0.58) CYP19A1CA1CA2ALDH1A1CYP1A2
SCHEMBL7123887 0.87 CYP19A1 (0.60) CYP19A1CA1CA2ALDH1A1CYP1A2
SCHEMBL15103561 0.87 CA1 (0.63) CYP19A1CA1CA2ALDH1A1CYP1A2
SCHEMBL7125137 0.85 CYP19A1 (0.57) CYP19A1CA1CA2ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2003504327-A 2003-02-04 JP claimed
EP-1223928-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS Prendergast, Patrick Thomas (IE) 2002-07-24 EP claimed
WO-2001003681-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS PRENDERGAST PATRICK T (IE) 2001-01-18 WO claimed
US-6555523-B1 Such as 3',4'-diacetoxy-5,6,7-trimethoxyflavone or naringin in the treatment HIV, picornavirus, and/or respiratory virus CASCADE ESTATES LTD. (MU) 2003-04-29 US disclosed
EP-1223928-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS Prendergast, Patrick Thomas (IE) 2002-07-24 EP disclosed
WO-2001003681-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS PRENDERGAST PATRICK T (IE) 2001-01-18 WO disclosed